AAIC 2025 Abstract
Integrating Plasma pTau‐217 and Aβ42/Aβ40 Ratio for Accurate Non‐Invasive Prediction of Brain Amyloid Accumulation
Study in peopleBiomarkers
Abstract
Background: The identification of individuals with amyloid‐beta (Aβ) brain accumulation is crucial for the early diagnosis and management of Alzheimer's disease (AD). Plasma biomarkers have emerged as promising non‐invasive tools for this purpose.
